Thursday, 17 November 2016

Targeting Mycothiol Biosynthesis and Mycothiol-Dependent Detoxification for the Treatment of Tuberculosis

Tuberculosis (TB) is an infectious disease that dates back to ancient and historical times. Mycobacterium tuberculosis is the primary organism responsible for TB, the number two single agent infectious disease killer worldwide behind HIV. In spite of the fact that there are currently effective drugs for the treatment of TB available, this disease continues to be a global problem. In 2011, there were an estimated 8.7 million new cases of TB and 1.4 million deaths attributedto TB worldwide. 

Tuberculosis


Treatment of TB is difficult, requires multidrug therapy for extended periods of time (6-9 months), and is often unsuccessful. The difficulty in TB treatment is attributed to the slow growth rate and resilience of the M. tuberculosis organism in adapting to changes in oxygen and nitric oxide levels, pH, metal ion concentrations, and available nutrients that allow for mycobacterial survival in host macrophages , as well as the high degree of drug resistance associated with M. tuberculosis.  Read more...................

No comments:

Post a Comment